Article Details
Retrieved on: 2018-05-07 22:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Zacks Investment Research downgraded BioMarin Pharmaceutical from a “buy” ... Finally, <b>Quantum Capital Management</b> grew its stake in BioMarin ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here